St. Petersburg, FL (PRWEB) April 01, 2014

Sublime Beauty has recently introduced its newest serum which makes a positive impact on aging skin within 30 days.

Cell Renewal | Fibroblast Serum is discounted 35% for 2 days only at the company webstore, SublimeBeautyShop with coupon code CELLRENEW35.

"A key ingredient is Human Fibroblast Conditioned Media, rich in proteins and growth factors, that instruct the skin's fibroblasts to product collagen," says Kathy Heshelow, founder of Sublime Beauty. "The non-embryonic stem cells are powerful indeed - no fillers are used."

The company offers a free brochure about the ingredients on the product page. "We find that our customers want to know about ingredients in the product, what they do and what to expect." says Heshelow. "We offer lots of education on our products."

Sublime Beauty focuses on anti-aging and healthy-skin oriented products, from Skin Brushing and collagen boosters to organic products for the skin. It specializes in serums.

The company offers free standard shipping within the continental U.S and a Sublime Beauty VIP Club. Interested clients can sign up for secret deals and deep discounts as well.

The 35% off sale ends Wednesday at midnight.

Go here to see the original:
The New Scientific Serum That Helps Skin Become Younger and Healthier on Sale at Sublime Beauty Now

Just weeks after invalidating a groundbreaking paper describing a simple technique for generating pluripotent stem cells, professor Kenneth Ka Ho Lee now believes he has identified the correct approach.

Lee, chief of stem cell research at the Chinese University of Hong, spoke to Wired.co.uk in March about his tentative excitement when he read the Nature study in question, published at the start of the year. The proposed Stap cells (stimulus-triggered acquisition of pluripotency) in it were a revelation, because they suggested there was a simple way to generate embryonic-like stem cells that could potentially be used in the treatment of diseases such as Parkinson's. The method involved reprogramming a donor's own adult blood and skin cells (in this case, mice) by exposing them to extreme trauma, such as an acid bath.

Lee could see its potential, but like the rest of the community he had his doubts. While reports circulated that the images published in the Nature study also featured in older papers penned by lead researcher Haruko Obokata of Japan's Riken Centre, Lee set about trying to replicate the experiment himself.

It didn't work.

Since then the Riken Centre has launched an investigation into the legitimacy of the trial, and that investigation today revealed Obokata had indeed falsified information, including results and images of DNA fragments used.

"Actions like this completely destroy data credibility," commented Shunsuke Ishii, head of the investigative committee and a Riken molecular geneticist, at a press conference. "There is no doubt that she was fully aware of this danger. We've therefore concluded this was an act of research misconduct involving fabrication." Obokata has denied the allegations, but Riken says its own research team will be the one to verify the results and carry out the experiment again.

In the interim however, a coauthor on the paper at the centre of the debacle,Charles Vacanti published yet another protocol for the Stap technique. Vacanti, of ear-on-a-mouse fame, is a professor at Harvard Medical School and published online what he said was found to be "an effective protocol for generating Stap cells in our lab, regardless of the cell type being studied". It was a combination of the two approaches mentioned in the Naturepaper -- the acid bath, and the trituration process (the application of pressure on the cells using pipettes to induce stress). He describes the latter process as being exerted with force, more so than in the original paper, and over a lengthy period -- twice a day for the first week.

Nature had already rejected Lee's version of experiments for publication last month. Undeterred, he set about applying Vacanti's technique. Liveblogging the experiments on ResearchGate, the open source platform where Lee had published his first set of experiments, the Hong Kong researcher immediately saw the excess stress was leading to rapid cell death among the lung fibroblast cells used.

"We estimated that there was a 50 percent decrease in cell number," Lee wrote four days ago on the blog. "In the original paper reported in Nature, such decrease in cell count was reported for day two, which is inline with our current experiment. Day three will be critical as this was the time Oct4-GFP expression [an indication that stem cells are generating] was reported for Stap cells. If we find that the cell number decreased even more drastically in our cultures, we will harvest some of the cultures and use them directly for qPCR analysis [quantitative polymerase chain reaction,a screening technique for stem cells]."

Nevertheless, things appeared to turn around. In his preliminary studies Lee has concluded that it could be the extreme stress through trituration, and not the acid bath, that was responsible for creating the Stap cells. "I am shocked and amazed by the qPCR results for the three-day-old control and Stap cultures," he wrote on ResearchGate, alongside a graph of the results. "Totally speechless!"

Link:
'Fabricated' stem cell paper may have just been proven valid

Viruses were traditionally thought to be malicious nanoscopic bearers of death and destruction. But modern science has suggested that while that is sometimes the case, the relationship between viruses and living organisms is a complicated one, as is the question of whether viruses can be truly considered "living" organisms. I. Viruses Can Actually be Useful, Sometimes In case newly discovered mega-viruses -- which rival small bacteria in size, function, and genetic complexity (and are sometimes "infected" by other viruses) -- aren't mind-warping enough, recent evidence suggests that as much of 8 percent of the genetic material found in higher organisms such as humans may be "borrowed" from viral genomes. These pieces of DNA are identifiable, if you know what you're looking for, but long ago lost their ability to depart and jump to new hosts. In that regard, mankind can be viewed as similar in some ways to lichen -- as a collection of multiple fused "organisms" living as one -- as modern man's genetic code consists of virus and traditional eukaryotic genes functioning side by side. The latest wild discovery comes courtesy of Montreal, Quebec, Canada's McGill University.

Professor Bourque states in an interview with National Geographic:

[Acquiring useful genes from viruses] can be faster than just relying on random mutations to get something that might work.

[These genes should be examined] to see if they have also evolved new functional roles, like HERV-H did in stem cells. We suspect that these genes may play important roles in other cell types as well, such as liver, kidney, and brain.

Sources: NATURE STRUCTURAL & MOLECULAR BIOLOGY, National Geographic

Original post:
Primate Stem Cell Creation Appears Driven by Genes From Ancient Virus

Heather Burke - Stem Cell Therapy for treating her Multiple Sclerosis
Heather Burke, a 26-year-old mother of two is about to embark on a medical journey that could stop her multiple sclerosis in its tracks. The disease, which a...

By: DIAD0NU

Original post:
Heather Burke - Stem Cell Therapy for treating her Multiple Sclerosis - Video

April 1, 2014

University of Nottingham

Scientists at The University of Nottingham have developed a new substance which could simplify the manufacture of cell therapy in the pioneering world of regenerative medicine.

Cell therapy is an exciting and rapidly developing area of medicine in which stem cells have the potential to repair human tissue and maintain organ function in chronic disease and age-related illnesses. But a major problem with translating current successful research into actual products and treatments is how to mass-produce such a complex living material.

There are two distinct phases in the production of stem cell products; proliferation (making enough cells to form large tissue) and differentiation (turning the basic stem cells into functional cells). The material environment required for these two phases are different and up to now a single substance that does both jobs has not been available.

Now a multi-disciplinary team of researchers at Nottingham has created a new stem cell micro-environment which they have found has allowed both the self-renewal of cells and then their evolution into cardiomyocyte (heart) cells. The material is a hydrogel containing two polymers an alginate-rich environment which allows proliferation of cells with a simple chemical switch to render the environment collagen-rich when the cell population is large enough. This change triggers the next stage of cell growth when cells develop a specific purpose.

Major priority

Professor of Advanced Drug Delivery and Tissue Engineering, Kevin Shakesheff, said:

Our new combination of hydrogels is a first. It allows dense tissue structures to be produced from human pluripotent stem cells (HPSC) in a single step process never achieved before. The discovery has important implications for the future of manufacturing in regenerative medicine. This field of healthcare is a major priority for the UK and we are seeing increasing investment in future manufacturing processes to ensure we are ready to deliver real treatments to patients when HPSC products and treatments go to trial and become standard.

The research, Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation, is published in the Proceedings of the National Academy of Sciences (PNAS).

More here:
Big Breakthrough In Stem Cell Manufacturing Technology

Dr Antonia Park, according to the Professional Regulatory Commission, is not authorized to practice medicine in the Philippines. She faces charges of estafa and reckless imprudence resulting in homicide.

MANILA, Philippines The alternative medicine doctor who took in former president Gloria Macapagal-Arroyo in 2012 for possible stem cell therapy is not licensed to practice in the Philippines.

On Tuesday, April 1, Antonia Park of the Green & Young Health & Wellness Center admitted to Rappler in a phone interview she is not a registered physician in the Philippines because "I'm not from here." She is instead a registered medical practitioner in London and Korea.

"Thats why its a wellness center. If dito ako [registered], maglalagay na lang ako ng medical center," she said, referring to her center located in Tagaytay City. (That's why it's a wellness center. If I am registered here, I might as well put up a medical center.)

A document from the Professional Regulatory Commission (PRC) dated Aug 12, 2013 showed Park is not in the database of physicians which contains the names of those duly authorized to practice medicine in the Philippines.

Certification Antonia Carandang Park

Park and some of her clinic staff are facing charges of estafa and reckless imprudence resulting in homicide. The charges were filed last year by businessman Bernard Tan with the National Bureau of Investigation (NBI) after his 23-year-old daughter Kate died.

Kate, an Ateneo student who graduated with honors in March 2013, died 4 months later on July 4, due to a tumor that blocked the entry of blood to her heart, secondary to Hodgkin's Lymphoma. The disease is an uncommon but curable cancer of the lymphatic system.

High-profile patient

Read the original here:
Arroyo's alternative medicine doctor unlicensed

Charles Q. Choi

A virus that invaded the genomes of humanity's ancestors millions of years ago now plays a critical role in the embryonic stem cells from which all cells in the human body derive, new research shows.

The discovery sheds light on the role viruses play in human evolution and could help scientists better understand how to use stem cells in advanced therapies or even how to convert normal cells into stem cells.

Embryonic stem cells are pluripotent, meaning they are capable of becoming any other kind of cell in the body. Scientists around the world hope to use this capability to help patients recover from injury and disease.

Researchers have struggled for decades to figure out how pluripotency works. These new findings reveal that "material from viruses is vital in making human embryonic stem cells what they are," said computational biologist Guillaume Bourque at McGill University in Montreal, a co-author of the study published online March 30 in Nature Structural & Molecular Biology.

Viral Invasion

To make copies of itself, a virus has to get inside a cell and co-opt its machinery. When one type of virus called a retrovirus does this, it slips its own genes into the DNA of its host cell. The cell is then tricked into assembling new copies of the retrovirus. The most infamous retrovirus is HIV, the virus behind AIDS.

In rare cases, retroviruses infect sperm or egg cells. If that sperm or egg becomes part of a person, their cells will contain retrovirus DNA, and they can pass that DNA on to their descendants. Past research suggests that at least 8 percent of the human genome is composed of these so-called endogenous retroviruses-leftovers from retroviral infections our ancestors had millions of years ago.

Scientists long thought that endogenous retroviruses were junk DNA that didn't do anything within the human genome, said study co-author Huck-Hui Ng, a molecular biologist at the Genome Institute of Singapore.

However, recent studies have revealed that might not be true for one class of endogenous retroviruses known as human endogenous retrovirus subfamily H. HERV-H DNA was surprisingly active in human embryonic stem cells but not in other regular types of human cells.

Read the rest here:
Ancient Virus DNA Gives Stem Cells the Power to Transform

Stem Cell Therapy - 2
2 .

By: tscmru

Read the original here:
Stem Cell Therapy - 2 - Video

PUBLIC RELEASE DATE:

31-Mar-2014

Contact: Emma Rayner emma.rayner@nottingham.ac.uk 44-011-595-15793 University of Nottingham

Scientists at The University of Nottingham have developed a new substance which could simplify the manufacture of cell therapy in the pioneering world of regenerative medicine.

Cell therapy is an exciting and rapidly developing area of medicine in which stem cells have the potential to repair human tissue and maintain organ function in chronic disease and age-related illnesses. But a major problem with translating current successful research into actual products and treatments is how to mass-produce such a complex living material.

There are two distinct phases in the production of stem cell products; proliferation (making enough cells to form large tissue) and differentiation (turning the basic stem cells into functional cells). The material environment required for these two phases are different and up to now a single substance that does both jobs has not been available.

Now a multi-disciplinary team of researchers at Nottingham has created a new stem cell micro-environment which they have found has allowed both the self-renewal of cells and then their evolution into cardiomyocyte (heart) cells. The material is a hydrogel containing two polymers an alginate-rich environment which allows proliferation of cells with a simple chemical switch to render the environment collagen-rich when the cell population is large enough. This change triggers the next stage of cell growth when cells develop a specific purpose.

Professor of Advanced Drug Delivery and Tissue Engineering, Kevin Shakesheff, said:

"Our new combination of hydrogels is a first. It allows dense tissue structures to be produced from human pluripotent stem cells (HPSC) in a single step process never achieved before. The discovery has important implications for the future of manufacturing in regenerative medicine. This field of healthcare is a major priority for the UK and we are seeing increasing investment in future manufacturing processes to ensure we are ready to deliver real treatments to patients when HPSC products and treatments go to trial and become standard."

The research, Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation, is published in the Proceedings of the National Academy of Sciences (PNAS).

See the original post here:
Major breakthrough in stem cell manufacturing technology

Stem Cell Therapy - 4
4 .

By: tscmru

Continue reading here:
Stem Cell Therapy - 4 - Video

Stem Cell Therapy for Spinal Cord Injury: Jamie Richie discusses her improvements
Jamie Richie discussed her treatments and improvements while undergoing her third round of stem cell therapy at the Stem Cell Institute in Panama City, Panam...

By: http://www.cellmedicine.com

View post:
Stem Cell Therapy for Spinal Cord Injury: Jamie Richie discusses her improvements - Video

Aventura Hospital and Medical Center - Stem Cell Therapy
In this video Dr. Coy discusses how he is studying stem cells in the heart. Steam Cell Therapy is an exciting technology that is now harvesting cells that ar...

By: HCAEastFloridaHealth

See the article here:
Aventura Hospital and Medical Center - Stem Cell Therapy - Video

Brother describes pulling mudslide victim's body from car

By Jonathan Kaminsky DARRINGTON, Washington (Reuters) - Days after risking his own life and defying arrest by joining the search for Washington state mudslide victims in a vast, mucky debris field near Oso, Dayn Brunner retrieved the body of the No. 1 person he had been looking for - his sister. Brunner, 42, recounted the tragic coincidence in an interview with Reuters on Friday, two days after it unfolded on the enormous mound of mud and rubble left by last Saturday's disaster, which has claimed at least 26 lives and left 90 people still missing. Brunner said he was on the mud pile on Wednesday afternoon when other rescue workers found a blue object and called him over to the spot. It was the same color as the car his sister, Summer Raffo, 36, was known to have been driving through the area when the slide struck.

Read more:
Study Shows Neuralstem Cells Transplanted Into Brain Significantly Improve Post-Stroke Symptoms in Rats

George Washington University (GW) researcher Narine Sarvazyan, Ph.D., has invented a new organ to help return blood flow from veins lacking functional valves. A rhythmically contracting cuff made of cardiac muscle cells surrounds the vein acting as a 'mini heart' to aid blood flow through venous segments. The cuff can be made of a patient's own adult stem cells, eliminating the chance of implant rejection.

"We are suggesting, for the first time, to use stem cells to create, rather than just repair damaged organs," said Sarvazyan, professor of pharmacology and physiology at the GW School of Medicine and Health Sciences. "We can make a new heart outside of one's own heart, and by placing it in the lower extremities, significantly improve venous blood flow."

The novel approach of creating 'mini hearts' may help to solve a chronic widespread disease. Chronic venous insufficiency is one of the most pervasive diseases, particularly in developed countries. Its incidence can reach 20 to 30 percent in people over 50 years of age. It is also responsible for about 2 percent of health care costs in the United States. Additionally, sluggish venous blood flow is an issue for those with diseases such as diabetes, and for those with paralysis or recovering from surgery.

This potential new treatment option, outlined in a recently published paper in the Journal of Cardiovascular Pharmacology and Therapeutics, represents a leap for the tissue engineering field, advancing from organ repair to organ creation. Sarvazyan, together with members of her team, has demonstrated the feasibility of this novel approach in vitro and is currently working toward testing these devices in vivo.

Story Source:

The above story is based on materials provided by George Washington University. Note: Materials may be edited for content and length.

View post:
'Mini heart' invented to help return venous blood

When someone has chronic venous insufficiency, it means that because of faulty valves in their leg veins, oxygen-poor blood isn't able to be pumped back to their heart. The George Washington University's Dr. Narine Sarvazyan has created a possible solution, however a beating "mini heart" that's wrapped around the vein, to help push the blood through.

The mini heart takes the form of a cuff of rhythmically-contracting heart tissue, made by coaxing the patient's own adult stem cells into becoming cardiac cells. When one of those cuffs is placed around a vein, its contractions aid in the unidirectional flow of blood, plus it helps keep the vein from becoming distended. Additionally, because it's grown from the patient's own cells, there's little chance of rejection.

So far, the cuffs have been grown in the lab, where they've also been tested. Soon, however, Sarvazyan hopes to conduct animal trials, in which the cuffs are actually grown on the vein, in the body.

"We are suggesting, for the first time, to use stem cells to create, rather than just repair damaged organs," she said. "We can make a new heart outside of ones own heart, and by placing it in the lower extremities, significantly improve venous blood flow."

Scientists at Germany's Fraunhofer Institute for Manufacturing Engineering and Automation are also working on a treatment for chronic venous insufficiency, although their approach has been to create artificial venous valves that could be used to replace the defective natural ones.

A paper on Sarvazyan's research was recently published in the Journal of Cardiovascular Pharmacology and Therapeutics. One of the mini hearts can be seen beating away, in the video below.

Source: The George Washington University

Read the original here:
"Mini hearts" on veins could be used to treat circulatory problems

LAKE MARY, Fla. (WOFL FOX 35 ORLANDO) -

A 26-year-old mother of two is about to embark on a medical journey that could stop her multiple sclerosis in its tracks. The disease, which attacks the central nervous system, affects more than 400,000 Americans.

There is no cure for multiple sclerosis, but Heather Nicole Burke believes the stem cell replacement procedure she is about to undergo could make a big difference.

Burke contacted FOX 35, because she wants others to know that the procedure. When Burke got news that her insurance would cover the still-experimental procedure, "I looked at my phone, and I was like, 'This is real! I'm going to get my life back! I'm going to be OK! I'm going to be able to take care of my children!'"

Burke will soon travel from Florida to Chicago for a multi-step stem cell therapy that could stop her disease from progressing.

Dr. Richard Burt, the chief or immunotherapy at Northwestern Memorial Hospital, and his team will use Burke's stem cells to reset her immune system.

"It generates an immune system that ends up -- in the process of doing that -- developing a tolerance to self which puts the disease in remission," Burt explained.

Burt has been performing the experimental procedure on humans since 2008. He said he sees only seven percent of patients relapse. Burt said he often finds insurance companies are willing to pay for the therapy.

"The majority of the time insurance does pay many of the major carriers pay. Medicare pays. Medicaid in the state of Illinois pays. It's a rare carrier that doesn't pay," Burt said.

Burke said her insurance will cover all of the $150,000 procedure. He called that a bargain, considering she is on 19 medications, one of which costs her insurance company $200,000 each year.

Read more from the original source:
Woman to undergo stem cell procedure to treat multiple sclerosis

PUBLIC RELEASE DATE:

27-Mar-2014

Contact: Lisa Anderson lisama2@gwu.edu 202-994-3121 George Washington University

WASHINGTON (March 27, 2014) George Washington University (GW) researcher Narine Sarvazyan, Ph.D., has invented a new organ to help return blood flow from veins lacking functional valves. A rhythmically contracting cuff made of cardiac muscle cells surrounds the vein acting as a 'mini heart' to aid blood flow through venous segments. The cuff can be made of a patient's own adult stem cells, eliminating the chance of implant rejection.

"We are suggesting, for the first time, to use stem cells to create, rather than just repair damaged organs," said Sarvazyan, professor of pharmacology and physiology at the GW School of Medicine and Health Sciences. "We can make a new heart outside of one's own heart, and by placing it in the lower extremities, significantly improve venous blood flow."

The novel approach of creating 'mini hearts' may help to solve a chronic widespread disease. Chronic venous insufficiency is one of the most pervasive diseases, particularly in developed countries. Its incidence can reach 20 to 30 percent in people over 50 years of age. It is also responsible for about 2 percent of health care costs in the United States. Additionally, sluggish venous blood flow is an issue for those with diseases such as diabetes, and for those with paralysis or recovering from surgery.

This potential new treatment option, outlined in a recently published paper in the Journal of Cardiovascular Pharmacology and Therapeutics, represents a leap for the tissue engineering field, advancing from organ repair to organ creation. Sarvazyan, together with members of her team, has demonstrated the feasibility of this novel approach in vitro and is currently working toward testing these devices in vivo.

###

The study, titled "Thinking Outside the Heart: Use of Engineered Cardiac Tissue for the Treatment of Chronic Deep Venous Insufficiency," is available at http://cpt.sagepub.com/content/early/2014/01/20/1074248413520343.full.

Media: To interview Dr. Sarvazyan about her research, please contact Lisa Anderson at lisama2@gwu.edu or 202-994-3121.

See more here:
GW researcher invents 'mini heart' to help return venous blood

Contact Information

Available for logged-in reporters only

Newswise WASHINGTON (March 27, 2014) George Washington University (GW) researcher Narine Sarvazyan, Ph.D., has invented a new organ to help return blood flow from veins lacking functional valves. A rhythmically contracting cuff made of cardiac muscle cells surrounds the vein acting as a 'mini heart' to aid blood flow through venous segments. The cuff can be made of a patients own adult stem cells, eliminating the chance of implant rejection.

We are suggesting, for the first time, to use stem cells to create, rather than just repair damaged organs, said Sarvazyan, professor of pharmacology and physiology at the GW School of Medicine and Health Sciences. We can make a new heart outside of ones own heart, and by placing it in the lower extremities, significantly improve venous blood flow.

The novel approach of creating mini hearts' may help to solve a chronic widespread disease. Chronic venous insufficiency is one of the most pervasive diseases, particularly in developed countries. Its incidence can reach 20 to 30 percent in people over 50 years of age. It is also responsible for about 2 percent of health care costs in the United States. Additionally, sluggish venous blood flow is an issue for those with diseases such as diabetes, and for those with paralysis or recovering from surgery.

This potential new treatment option, outlined in a recently published paper in the Journal of Cardiovascular Pharmacology and Therapeutics, represents a leap for the tissue engineering field, advancing from organ repair to organ creation. Sarvazyan, together with members of her team, has demonstrated the feasibility of this novel approach in vitro and is currently working toward testing these devices in vivo.

The study, titled Thinking Outside the Heart: Use of Engineered Cardiac Tissue for the Treatment of Chronic Deep Venous Insufficiency, is available at http://cpt.sagepub.com/content/early/2014/01/20/1074248413520343.full.

Media: To interview Dr. Sarvazyan about her research, please contact Lisa Anderson at lisama2@gwu.edu or 202-994-3121.

###

About the GW School of Medicine and Health Sciences:

Originally posted here:
Researcher Invents 'Mini Heart' to Help Return Venous Blood

Contact Information

Available for logged-in reporters only

Newswise LOS ANGELES (March 27, 2014) Two Cedars-Sinai Heart Institute physician-researchers have been named recipients of prestigious awards from the American College of Cardiology.

Eduardo Marbn, MD, PhD, director of the Cedars-Sinai Heart Institute and a pioneer in developing cardiac stem cell treatments, will be awarded the 2014 Distinguished Scientist Award (Basic Domain) by the 40,000-member medical society during its 63rd Annual Scientific Session on March 31.

Sumeet Chugh, MD, associate director of the Heart Institute and a leading expert on heart rhythm disorders such as sudden cardiac arrest and atrial fibrillation, is to receive the Simon Dack Award for Outstanding Scholarship in recognition of Chughs contributions to the organizations peer-reviewed medical journals.

Dr. Marbn has earned the prestigious title of Distinguished Scientist by pioneering the development of stem cell treatments that can regenerate healthy heart muscle, said Shlomo Melmed, MD, senior vice president of Academic Affairs, dean of the Cedars-Sinai medical faculty and the Helene A. and Philip E. Hixon Chair in Investigative Medicine. Dr. Chugh is leading the quest to unlock the mysteries of how to prevent sudden cardiac arrest, which is 99 percent fatal. Their work is advancing life-saving treatments for patients all over the world and is a testament to the outstanding work of the Heart Institute.

Using techniques that he invented to isolate and grow stem cells from a patient's own heart tissue, Marbn designed and completed the first-in-human cardiac stem cell trial, called CADUCEUS, funded by the National Institutes of Health. The study was the first to show that stem cell therapy can repair damage to the heart muscle caused by a heart attack. Currently, a new, multicenter stem cell clinical trial called ALLSTAR is measuring the effectiveness of donor heart stem cells in treating heart attack patients.

A native of Cuba, Marbn came to the United States with his parents at age 6 as a political refugee. He earned his bachelor's degree in mathematics from Wilkes College in Pennsylvania, and then attended the Yale University School of Medicine in a combined MD/PhD program. Among the many honors Marbn has received are the Basic Research Prize of the American Heart Association the Research Achievement Award of the International Society for Heart Research, the Gill Heart Institute Award and the Distinguished Scientist Award of the American Heart Association.

Chugh, the Pauline and Harold Price Chair in Cardiac Electrophysiology, is an expert in the performance of radio frequency ablation procedures as well as the use of pacemakers, defibrillators and biventricular devices to correct heart rhythm problems. The author of more than 250 articles and abstracts in professional journals, Chugh initiated and directs the ongoing Oregon Sudden Unexpected Death Study, a large, comprehensive assessment of sudden cardiac arrest in a community of 1 million residents. Chugh leads the World Health Organization panel that is charged with performing a worldwide assessment of heart rhythm disorders for the Global Burden of Disease Study.

After earning his medical degree from Government Medical College Patiala, India, Chugh spent the first year of his internal medicine residency at Tufts Newton Wellesley Hospital in Boston and the next two years at Hennepin County Medical Center in Minneapolis. He completed a fellowship in cardiology at the University of Minnesota and a fellowship in clinical cardiac electrophysiology at Mayo Clinic in Rochester, Minn.

Read more from the original source:
Two Cedars-Sinai Heart Institute Physicians Honored by American College of Cardiology

Ontario student Moneet Mann is coming to Surrey in her search for a bone marrow donor. Submitted/Vancouver Desi

MANPREET GREWAL VANCOUVER DESI

Will you marrow me?

A 24-year-old Brampton, Ont. girl is bringing her desperate search for a bone marrow match to Surrey this weekend.

Moneet Mann was studying to be a teacher at Thunder Bays Lakehead University when she was diagnosed with acute myeloid leukemia in October last year.

Although the news has been devastating for her and her family, she has chosen to see the blessing in her early diagnoses. With a stem cell transplant she can get back to her life, her school, her friends and passion to teach children.

But her challenge is that a perfect bone marrow match isnt always available in extreme cases, the odds of a match may be as little as one in 750,000.

Since her diagnosis shes started up her Will You Marrow Me? campaign to hunt for a donor, which will be holding a swabbing event alongside Canadian Blood Services at Surreys Dukh Nivaran Gurdwara on Sunday. Mann is particularly putting the call out to South Asian donors between the ages of 17 to 35.

According to Canadian Blood Services, matching between donor and patient happens on a genetic level. What this means is that if a patient is from a certain ethnic background, their donor is most likely going to be from the same ethnic group.

Doctors consider young men to be optimal donors because stem cells from young men can produce fewer chances of complications post-transplant. Also, men are typically physically bigger than women, so they can produce a greater volume of stem cells for the patient.

Link:
Ontario student's search for bone marrow donor brings her to Surrey